TGFB1 and ovarian cancer: By identifying thousands of SMAD4 binding loci as well as regulated genes, our data provide both a new resource for studying the mechanism underlying dysregulated TGFβ signaling in ovarian cancer cells as well as potential prognostic biomarkers for future ovarian cancer translational research.